Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 151-161

  Rothman, Richard B ^a   Jayanthi, Subramaniam ^a   Cadet, Jean L ^a   Wang, Xiaoying ^a   Dersch, Christina M ^a   Baumann, Michael H ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Amphetamine; Fenfluramine; Neurotoxicity; Parachloroamphetamine; Serotonin transporter

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHLORAMPHETAMINE; DEXFENFLURAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN; CAUDATE NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; FRONTAL CORTEX; LIGAND BINDING; MALE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SEROTONIN RELEASE; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALIA;

EID: 10444253962     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.020     Document Type: Conference Paper

References (24)

1. ROTHMAN, R.B. et al. 2003. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse 50: 233-239.
2. MCCANN, U.D. et al. 1997. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the literature. JAMA 278: 666-672.
3. ZACZEK, R. et al. 1990. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. J. Pharmacol. Exp. Ther. 253: 104-112.
4. O'CALLAGHAN, J.P. & D.B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 741-751.
5. ROWLAND, N.E. et al. 1993. Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions. Brain Res. 624: 35-43.
6. BRADFORD, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
7. 125I]RTI-55. J. Pharmacol. Exp. Ther. 270: 296-309.
8. ROTHMAN, R.B. 1986. Binding surface analysis: an intuitive yet quantitative method for the design and analysis of ligand binding studies. Alcohol Drug Res. 6: 309-325.
9. GREINER, E. et al. 2003. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) piperazine. J. Med. Chem. 46: 1465-1469.
10. JAYANTHI, S. et al. 2002. Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61: 1124-1131.
11. HUETHER, G., D. ZHOU & E. RUTHER. 1997. Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. J. Neural Transm. 104: 993-1004.
12. MOLLIVER, D.C. & M.E. MOLLIVER. 1990. Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat. Brain Res. 511: 165-168.
13. MAMOUNAS, L.A. et al. 1995. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15: 7929-7939.
14. BAUMAN, A.L. et al. 2000. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20: 7571-7578.
15. RAMAMOORTHY, S. & R.D. BLAKELY. 1999. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285: 763-766.
16. BLAKELY, R.D. & A.L. BAUMAN. 2000. Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol. 10: 328-336.
17. BAUMANN, M.H., M.A. AYESTAS & R.B. ROTHMAN. 1998. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats. J. Neurosci. 18: 9069-9077.
18. BAUMANN, M.H. et al. 2000. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity. Ann. N.Y. Acad. Sci. 914: 172-186.
19. FASCIANO, J. et al. 1997. N-methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects. Brain Res. 771: 115-120.
20. 3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment. J. Neurochem. 58: 250-257.
21. ZHOU, D. et al. 1996. Rat strain differences in the vulnerability of serotonergic nerve endings to neurotoxic damage by p-chloroamphetamine. J. Neural Transm. 103: 1381-1395.
22. RIDET, J.L., M. GEFFARD & A. PRIVAT. 1994. Light and electron microscopic studies of the effects of p-chloroamphetamine on the monoaminergic innervation of the rat spinal cord. J. Comp. Neurol. 343: 281-296.
23. HARING, J.H., L. MEYERSON & T.L. HOFFMAN. 1992. Effects of para-chloroamphetamine upon the serotonergic innervation of the rat hippocampus. Brain Res. 577: 253-260.
24. APPEL, N.M. et al. 1990. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 6: 33-44.